These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8216179)

  • 1. Effects of arginine-vasopressin on regional blood volume distribution in supine humans.
    Hopf HB; Stühmeier KD; Klement W; Langen KJ; Peters J
    Basic Res Cardiol; 1993; 88(3):297-306. PubMed ID: 8216179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin dose-response effects on fetal vascular pressures, heart rate, and blood volume.
    Tomita H; Brace RA; Cheung CY; Longo LD
    Am J Physiol; 1985 Nov; 249(5 Pt 2):H974-80. PubMed ID: 3933366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole body vascular capacitance response to vasopressin is mediated by autonomic function.
    Martin DS; McNeill JR
    Am J Physiol; 1991 Aug; 261(2 Pt 2):H493-9. PubMed ID: 1877675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of NG-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats.
    Gardiner SM; Compton AM; Kemp PA; Bennett T
    Br J Pharmacol; 1991 Jan; 102(1):65-72. PubMed ID: 2043932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide decreases hepatic and cardiac blood content, but increases intestinal blood content in supine humans.
    Peters J; Neuser D; Schaden W; Arndt JO
    Basic Res Cardiol; 1992; 87(3):250-62. PubMed ID: 1325772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroergotamine decreases the blood content in the skeletal musculature but etilefrine hydrochloride in the splanchnic region in man.
    Arndt JO; Höck A; Inoue K
    Basic Res Cardiol; 1984; 79(2):244-52. PubMed ID: 6146305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baroreceptor-mediated suppression of osmotically stimulated vasopressin in normal humans.
    Goldsmith SR
    J Appl Physiol (1985); 1988 Sep; 65(3):1226-30. PubMed ID: 3182493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional blood volume distribution during positive and negative airway pressure breathing in supine humans.
    Peters J; Hecker B; Neuser D; Schaden W
    J Appl Physiol (1985); 1993 Oct; 75(4):1740-7. PubMed ID: 8282628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine vasopressin increases apparent whole body capacity in anesthetized cats.
    Martin DS; McNeill JR
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H722-8. PubMed ID: 2316687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of posture on the changes in plasma atrial natriuretic factor and arginine vasopressin levels during immersion.
    Wolf JP; Nguyen NU; Baulay A; Dumoulin G; Berthelay S
    Eur J Appl Physiol Occup Physiol; 1990; 61(3-4):284-8. PubMed ID: 2149337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic effects of vasopressin on fluid volume distribution in conscious dogs.
    Merrill DC; Cowley AW
    Am J Physiol; 1987 Jan; 252(1 Pt 2):F26-31. PubMed ID: 3812701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on intravascular pressures of vasopressin and angiotensin II in dogs.
    Bie P; Warberg J
    Am J Physiol; 1983 Dec; 245(6):R906-14. PubMed ID: 6362439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
    Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
    Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin and ANG II in the control of ACTH secretion and arterial and atrial pressures.
    Brooks VL
    Am J Physiol; 1989 Feb; 256(2 Pt 2):R339-47. PubMed ID: 2537037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
    J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid increase in desflurane concentration is associated with greater transient cardiovascular stimulation than with rapid increase in isoflurane concentration in humans.
    Weiskopf RB; Moore MA; Eger EI; Noorani M; McKay L; Chortkoff B; Hart PS; Damask M
    Anesthesiology; 1994 May; 80(5):1035-45. PubMed ID: 8017643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in male and female rats.
    Stallone JN
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R40-9. PubMed ID: 7840337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vasopressin on the circulation and its baroreflex control in healthy men.
    Aylward PE; Floras JS; Leimbach WN; Abboud FM
    Circulation; 1986 Jun; 73(6):1145-54. PubMed ID: 3698249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressor and intestinal vascular bed responses to vasopressin after cholinergic blockade.
    Martin DS; McNeill JR
    Am J Physiol; 1988 Jan; 254(1 Pt 2):H45-51. PubMed ID: 3337258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.